Growth Metrics

Lexicon Pharmaceuticals (LXRX) Change in Receivables: 2009-2012

Historic Change in Receivables for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to $1.1 million.

  • Lexicon Pharmaceuticals' Change in Receivables rose 923.74% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.0 million, marking a year-over-year increase of 360.91%. This contributed to the annual value of $2.5 million for FY2024, which is 150.81% up from last year.
  • As of Q4 2012, Lexicon Pharmaceuticals' Change in Receivables stood at $1.1 million, which was up 2,145.10% from $51,000 recorded in Q3 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Change in Receivables ranged from a high of $1.6 million in Q2 2010 and a low of -$743,000 during Q3 2010.
  • Moreover, its 3-year median value for Change in Receivables was -$77,500 (2011), whereas its average is $12,167.
  • Examining YoY changes over the last 5 years, Lexicon Pharmaceuticals' Change in Receivables showed a top increase of 923.74% in 2012 and a maximum decrease of 288.51% in 2012.
  • Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Change in Receivables stood at $1.0 million in 2009, then plummeted by 158.09% to -$596,000 in 2010, then spiked by 76.68% to -$139,000 in 2011, then soared by 923.74% to $1.1 million in 2012.
  • Its Change in Receivables stands at $1.1 million for Q4 2012, versus $51,000 for Q3 2012 and -$4,000 for Q2 2012.